Thiol containing antioxidant drugs and the human immune system

R. Stagnaro, I. Pierri, P. Piovano, F. Baracco, M. De Palma, F. Indiveri

Research output: Contribution to journalArticle

Abstract

The over production of toxic oxygen species (TOS) by the phagocytic cells involved in inflammatory processes plays a crucial role in generating the immune defects which characterize both infections and neoplastic diseases. Since the thiol containing drugs, and N-acetylcysteine possess a high capacity for scavenging and inhibiting TOS, the question of whether these substances are able to protect, in vivo as well as in vitro, the function of lymphocytes isolated from the peripheral blood in patients suffering from chronic pulmonary diseases (CPD) was investigated. The lymphocytes isolated from healthy donors as well as those from CPD patients exposed in vitro to TOS showed a reduced viability and an impairment of functions in: (a) the ability to express HLA Class II and TAC antigens and (b) the capacity to stimulate and proliferate in allogenic (MLR) and autologous mixed lymphocyte reactions (AMLR). The presence of NAC or CAT blocked this toxicity. Cells isolated from healthy donors and patients following treatment with NAC were less sensitive to the in vitro toxicity of TOS.

Original languageEnglish
Pages (from-to)303-307
Number of pages5
JournalClinical Respiratory Physiology
Volume23
Issue number4
Publication statusPublished - 1987

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Fingerprint Dive into the research topics of 'Thiol containing antioxidant drugs and the human immune system'. Together they form a unique fingerprint.

  • Cite this

    Stagnaro, R., Pierri, I., Piovano, P., Baracco, F., De Palma, M., & Indiveri, F. (1987). Thiol containing antioxidant drugs and the human immune system. Clinical Respiratory Physiology, 23(4), 303-307.